Gemzar in combination with carboplatin is indicated for the treatment of patients with advanced that has relapsed at least 6 months after completion of platinum-based .
Gemzar in combination with paclitaxel is indicated for the first-line treatment of patients with metastatic cancer after failure of prior anthracycline-containing , unless anthracyclines were clinically contraindicated.
Gemzar is indicated in combination with for the first-line treatment of patients with inoperable, locally advanced ( IIIA or IIIB), or metastatic (Stage IV) non-small lung cancer.
Gemzar is indicated as first-line treatment for patients with locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) of the . Gemzar is indicated for patients previously treated with .